Viridian Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Updates

Go back to Viridian Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Updates
(NASDAQ: VRDN) Delayed: 22.92 -0.04 (0.17%)
Previous Close $22.96    52 Week High
Open $22.62    52 Week Low
Day High $23.03    P/E N/A 
Day Low $22.62    EPS
Volume 759,916